Design issues for conducting cost-effectiveness analyses alongside clinical trials.

Area of Science:

• Health Economics
• Clinical Trial Design
• Medical Technology Assessment

Background:

• Rising demand for economic data on new medical technologies necessitates integrating cost-effectiveness studies with clinical trials.
• Historical differences in methodology between cost-effectiveness studies and clinical trials pose design challenges for hybrid trials.

Purpose of the Study:

• To provide guidance on designing joint clinical/economic trials.
• To address the unique considerations for incorporating cost-effectiveness evaluations within clinical trial frameworks.
• To ensure comprehensive outcome data collection for robust economic evaluations.

Main Methods:

• Discussion of key design aspects including study perspective, hypothesis testing, and sample size estimation.
• Outline of methods for collecting both cost and outcome data within a unified trial structure.
• Identification of potential threats to the external validity of cost-effectiveness results.

Main Results:

• Comprehensive outcome measures (e.g., quality of life) enhance interpretation of clinical trial endpoints.
• Integrated data collection provides a basis for estimating intervention cost-effectiveness.
• Proactive identification and mitigation of design flaws improve the external validity of economic findings.

Conclusions:

• Careful design of joint clinical/economic trials is crucial for generating timely and relevant economic data.
• Addressing methodological differences and potential validity threats during the design phase is essential.
• Hybrid trials offer a valuable approach for evaluating the cost-effectiveness of novel medical technologies.